Locol and alanine aminotransferase increased Patient Reports February 12, 2012

Locol Side Effects Report #4841846-5
Locol side effect was reported by a Physician from GERMANY on Nov 07, 2005. Female patient, 72 years of age, weighting 134.5 lb, was diagnosed with hyperlipidaemia and was treated with Locol. After drug was administered, patient experienced the following side effects: acholia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholestasis, eosinophilia, gamma-glutamyltransferase increased, hepatotoxicity. Locol dosage: 40 MG, QD. Patient recovered.

Locol Side Effects Report #4887445-0
Locol side effect was reported by a Physician from GERMANY on Nov 07, 2005. Female patient, 72 years of age, weighting 134.5 lb, was diagnosed with hyperlipidaemia and was treated with Locol. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholestasis, eosinophilia, gamma-glutamyltransferase increased, hepatotoxicity, hyperbilirubinaemia. Locol dosage: 40 MG, QD. During the same period patient was treated with BETA BLOCKING AGENTS, ASPIRIN. Patient recovered.

Locol Side Effects Report #4917355-1
Locol side effect was reported by a Physician from GERMANY on Nov 07, 2005. Female patient, 72 years of age, weighting 134.5 lb, was diagnosed with hyperlipidaemia and was treated with Locol. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholestasis, eosinophilia, gamma-glutamyltransferase increased, hepatotoxicity, hyperbilirubinaemia. Locol dosage: 40 MG, QD. During the same period patient was treated with BETA BLOCKING AGENTS, ASPIRIN. Patient recovered.

Locol Side Effects Report #4612977-X
Locol side effect was reported by a Physician from on Mar 01, 2005. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with hypercholesterolaemia and was treated with Locol. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, circulatory collapse, diarrhoea. Locol dosage: 80 MG, QD. Patient recovered.


Locol Side Effects Report #5601434-X
Locol side effect was reported by a Physician from GERMANY on Jan 17, 2008. Female patient, 68 years of age, weighting 145.5 lb, was diagnosed with hypercholesterolaemia, back pain  and was treated with Locol. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, c-reactive protein increased, gamma-glutamyltransferase increased, glomerular filtration rate decreased, hepatic enzyme increased. Locol dosage: unknown. During the same period patient was treated with KATADOLON. Patient recovered.

Locol Side Effects Report #5026119-2
Locol side effect was reported by a Physician from GERMANY on May 16, 2006. Female patient, 38 years of age, weighting 121.3 lb, was diagnosed with hypercholesterolaemia and was treated with Locol. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver function test abnormal, malaise, syncope. Locol dosage: 80 MG, QD. Patient was hospitalized. Patient recovered.

Locol Side Effects Report #4766162-1
Locol side effect was reported by a Physician from GERMANY on Dec 09, 2004. Female patient was diagnosed with coronary artery disease  and was treated with Locol. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood creatine phosphokinase mb increased, dyspnoea, muscular weakness, myalgia, rhabdomyolysis. Locol dosage: 80 MG, QD. During the same period patient was treated with SERTRALINE, PIRACETAM, GABAPENTIN, TESTOSTERONE. Patient was hospitalized. Patient recovered.